Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-03 6:10 pm Purchase | 2024-12-31 | 13G | ADC Therapeutics SA ADCT | BlackRock Inc. BLK | 5,011,857 5.200% | 5,011,857 (New Position) | Filing History |
| 2024-11-14 9:00 pm Purchase | 2024-09-30 | 13G | ADC Therapeutics SA ADCT | Redmile Group LLC | 15,669,217 16.200% | 340,900 (+2.22%) | Filing History |
| 2024-11-13 08:58 am Sale | 2024-09-30 | 13G | ADC Therapeutics SA ADCT | Prosight Management LP | 9,617,531 9.950% | -9,486 (-0.10%) | Filing History |
| 2024-11-13 08:30 am Purchase | 2024-09-30 | 13G | ADC Therapeutics SA ADCT | Prosight Management LP | 9,627,017 9.960% | 3,155,217 (+48.75%) | Filing History |
| 2024-05-03 9:31 pm Purchase | 2024-04-25 | 13G | ADC Therapeutics SA ADCT | Oaktree Fund Advisors, LLC | 4,280,660 5.190% | 4,280,660 (New Position) | Filing History |
| 2024-04-25 4:10 pm Sale | 2024-04-23 | 13D | ADC Therapeutics SA ADCT | AUVEN THERAPEUTICS HOLDINGS LP | 2,255,719 2.700% | -4,074,829 (-64.37%) | Filing History |
| 2024-02-14 4:26 pm Purchase | 2023-12-31 | 13G | ADC Therapeutics SA ADCT | Redmile Group LLC | 15,328,317 18.800% | 1,763,068 (+13.00%) | Filing History |
| 2024-02-13 09:47 am Purchase | 2023-12-31 | 13G | ADC Therapeutics SA ADCT | Prosight Management LP | 6,471,800 8.000% | 2,167,282 (+50.35%) | Filing History |
| 2024-02-12 10:13 am Unchanged | 2023-12-31 | 13G | ADC Therapeutics SA ADCT | AstraZeneca PLC | 4,011,215 4.880% | 0 (Unchanged) | Filing History |
| 2023-04-28 4:08 pm Unchanged | 2023-04-27 | 13D | ADC Therapeutics SA ADCT | AUVEN THERAPEUTICS HOLDINGS LP | 6,330,548 7.900% | 0 (Unchanged) | Filing History |
| 2023-04-14 5:45 pm Purchase | 2023-04-06 | 13G | ADC Therapeutics SA ADCT | Prosight Management LP | 4,304,518 5.300% | 4,304,518 (New Position) | Filing History |
| 2023-04-10 09:37 am Sale | 2023-04-06 | 13G | ADC Therapeutics SA ADCT | FMR LLC | 40,444 0.050% | -4,613,009 (-99.13%) | Filing History |
| 2023-02-10 5:18 pm Purchase | 2022-12-31 | 13G | ADC Therapeutics SA ADCT | Redmile Group LLC | 13,565,249 16.800% | 6,114,220 (+82.06%) | Filing History |
| 2023-02-09 08:23 am Sale | 2023-02-09 | 13G | ADC Therapeutics SA ADCT | FMR LLC | 4,653,453 6.050% | -3,019,220 (-39.35%) | Filing History |
| 2023-02-06 2:56 pm Sale | 2023-02-02 | 13D | ADC Therapeutics SA ADCT | AUVEN THERAPEUTICS HOLDINGS LP | 6,330,548 7.900% | -12,000,000 (-65.46%) | Filing History |
| 2022-12-22 7:30 pm Unchanged | 2022-12-22 | 13D | ADC Therapeutics SA ADCT | AUVEN THERAPEUTICS HOLDINGS LP | 18,330,548 23.800% | 0 (Unchanged) | Filing History |
| 2022-12-09 4:06 pm Sale | 2022-12-08 | 13D | ADC Therapeutics SA ADCT | AUVEN THERAPEUTICS HOLDINGS LP | 18,330,548 23.800% | -3,088,182 (-14.42%) | Filing History |
| 2022-12-08 09:07 am Sale | 2022-12-08 | 13D | ADC Therapeutics SA ADCT | AUVEN THERAPEUTICS HOLDINGS LP | 21,418,730 27.800% | -775,000 (-3.49%) | Filing History |
| 2022-02-14 5:07 pm Purchase | 2021-12-31 | 13G | ADC Therapeutics SA ADCT | Redmile Group LLC | 7,451,029 9.700% | 692,235 (+10.24%) | Filing History |
| 2022-02-09 09:09 am Sale | 2022-02-08 | 13G | ADC Therapeutics SA ADCT | FMR LLC | 7,672,673 9.999% | -88,912 (-1.15%) | Filing History |